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Interstrand Crosslink Resistance in Escherichia coli

Abstract:

Interstrand crosslinks inhibit replica3on and transcrip3on in all cells,
leading to severe cellular toxicity.
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The model organism E. coli encodes genes for most of the cellular
processes thought to be involved in resistance to interstrand crosslinks
in human cells, including nucleo3de and base excision repair and
translesion DNA synthesis.
Therefore, we sought to iden3fy genes contribu3ng to ICL-resistance in
E. coli using targeted mutagenesis and a general selec3on scheme.
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Sequen=al selec=on and re-exposure of cultures to PUVA treatment led to increased resistance to
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Interstrand crosslinking agents are potent chemotherapeu3cs, yet
cancer cells o<en develop resistance to these drugs through unknown
mechanisms.
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Introduc=on:
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8-methoxypsoralen is a photoac3vated DNA-intercala3ng agent, which
a<er absorbing two high-energy UVA photons, covalently binds
pyrimidine bases on both DNA strands, to form an interstrand crosslink
(ICL). These lesions completely block replica3on and transcrip3on, and
are widely used in chemotherapies; yet the mechanism by which they
are processed remains poorly understood. In 1985, Ahmed and Holland
reported an Escherichia coli mutant demonstra3ng hyper-resistance to
ICL-inducing agents. The muta3on was mapped to 57.2 minutes on the
chromosome, and poten3ally encoded a 55-kDa protein that was
induced as part of the SOS response. Although these genes remain
uniden3ﬁed, hscA and hscB map to this loca3on, have a similar size, and
are SOS-inducible. To determine if these genes or others might confer
ICL resistance in E. coli, we characterized how cells survived PUVA
treatment in the absence of HscAB, and when these gene products were
overexpressed. In a second approach to screen for ICL resistance genes,
we developed a selec3on system to isolate hyper-resistant strains
through the sequen3al growth and exposure of wild-type cultures to
PUVA. We found no eﬀect on cell survival in the hscAB mutant
compared to its wild-type parent, sugges3ng that HscAB may not be
contribu3ng to ICL resistance as previously hypothesized. However, due
to the signiﬁcant cytotoxicity of plasmids containing hscAB, even in the
absence of PUVA treatment, we were unable to determine whether
over-expression of these gene products might provide a protec3ve
eﬀect to cells. Using itera3vely PUVA cells, we isolated strains that were
>104-fold more resistant to this ICL-inducing agent compared to the
parent strain. This result suggests that E. coli possess mechanisms to
repair or tolerate ICL’s that contribute to resistance to these agents,
similar to what is observed in human cancer cells.
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The absence of HscAB was found to have no measurable eﬀect on cell survival following PUVA treatment.
Plasmids containing HscAB were toxic to cells even in the absence of PUVA treatment, such that overexpression of HscAB as a mechanism of ICL resistance
could not be tested.
A popula3on of ICL hyper-resistant cells was isolated over successive genera3ons that had >104 magnitude of cell survival to PUVA treatment compared to its
wild-type parent. Sequencing of this hyper-resistant strain will be performed to iden3fy genes contribu3ng to the altered phenotype.
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